Episode 126: AML Series, Pt 12 - Treatment of patients with relapsed/refractory disease
The Fellow on Call: The Heme/Onc Podcast
Innovative Strategies in AML Treatment
This chapter explores treatment options for patients with relapsed/refractory acute myeloid leukemia (AML), focusing on regimens like FLAG and CLAG that enhance cytarabine's effectiveness. It also addresses the role of novel combinations, such as venetoclax, in improving outcomes for high-risk AML patients amid a lack of comprehensive randomized studies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
